Market Snapshot and Recent Performance

The stock of Smartfinancial Inc. (SMBK) experienced a modest decline of 0.77 % during the 24‑hour trading window that closed at 07:32 PM Central Europe on Wednesday, 21 October 2026. At the close, each share traded at approximately USD 49.37 on major exchanges. The company’s current supply of shares totals 17.1 million, and its market capitalization stands at USD 863.6 million. In the last 24 hours, roughly USD 11.7 million of Smartfinancial shares were exchanged.

Over the past month, Smartfinancial’s share price has fallen by 2.76 %. The 200‑day simple moving average sits at USD 44.72. In the past 52 weeks, the stock’s highest price was USD 54.14, recorded on 08 March 2026, while the low was USD 34.23 on 11 April 2025.


Corporate Highlights – Q3 2026 Results

On 19 October 2026, Smartfinancial Inc. released its third‑quarter 2026 earnings. Operating earnings rose to $1.10 per share, marking an improvement over the previous year. The company reported net loan and lease growth of $174 million—representing a 15 % annualised increase—while core deposit growth amounted to $163 million, a 12 % rise. Operating revenue reached $57.5 million, and net interest income showed modest growth relative to the prior quarter.

Credit quality remained stable, with non‑performing loans and leases at 0.28 % of total loans and leases. The allowance for credit losses decreased to 0.94 % of total loans. The balance sheet expanded, with total assets up by approximately $460 million, largely driven by a $493 million increase in loans and leases. Shareholders’ equity also increased, bolstered by a nine‑month net income of $48.6 million. The earnings release was accompanied by a conference call on 20 October and filed with the SEC under Form 8‑K.


In the same 24‑hour period, the following related equities moved as follows:

CompanyTicker24‑hour changeCurrent price (USD)Market cap (USD)P/E ratio
Excelerate EnergyEE+0.31 %33.071 bn21.47
Oil‑Dri of AmericaODC+2.65 %72.951 bn17.66
Avalyn PharmaAVLN+5.57 %25.221 bn–
Janux TherapeuticsJANX+2.75 %17.121 bn–
Marten TransportMRTN+0.16 %12.631 bn83.73

Excelerate Energy is slated to report its latest quarterly results on 4 November 2026, with analysts expecting modest earnings growth but a slight revenue decline relative to the same period a year earlier. Oil‑Dri of America disclosed insider transactions on 19 October 2026, indicating ongoing confidence among senior executives, yet no fundamental changes have been noted. Avalyn Pharma, Janux Therapeutics, and Marten Transport have all posted gains, with Marten Transport’s valuation driven by a notably high price‑to‑earnings ratio.


About Smartfinancial Inc.

Smartfinancial Inc. is a bank‑holding company headquartered in the United States. Through its subsidiaries, the firm offers a broad spectrum of financial services to both individuals and businesses. Products include savings accounts, mortgages, loans, deposits, debit cards, overdraft facilities, treasury management, online bill‑pay, and courier services. The company’s diversified portfolio and robust credit performance underpin its ongoing growth strategy and shareholder value creation.